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a  b  s  t  r  a  c  t
The  G protein-coupled  apelin  receptor  (APJ)  binds  the  endogenous  peptide  apelin  and  has  been  shown  to
have roles  in  many  physiological  systems.  Thus  far,  distribution  studies  have  predominantly  been con-
ducted  in  the  rat  and  there  is  limited  knowledge  of  the  cellular  distribution  of  APJ in  mouse  or human
tissues.  As  recent  functional  studies  have  been  conducted  in  APJ  knock-out  mice  (APJ KO),  in  this  study  we
undertook  to characterize  APJ  mRNA  and  I125[Pyr1]apelin-13  binding  site  distribution  in mouse  tissues
to  enable  correlation  of  distribution  with  function.  We  have  utilized  in  situ  hybridization  histochemistry
(ISHH)  using  APJ  riboprobes,  which  revealed  strong  hybridization  speciﬁcally  in  the  paraventricular  (PVN)
and supraoptic  (SON)  nuclei  of the  hypothalamus  and  in the  anterior  pituitary,  with  marginally  lower
levels  in  the posterior  pituitary.  In  the periphery,  strong  hybridization  was  observed  in  the  lung,  heart,
125 1utoradiography adrenal  cortex,  renal  medulla,  ovary  and  uterus.  Autoradiographic  binding  to  APJ with  I [Pyr ]apelin-13
exhibited  signiﬁcant  binding  in  the  anterior  pituitary,  while  lower  levels  were  observed  in the  posterior
pituitary  and  PVN  and  SON.  In  the  periphery,  strong  receptor  binding  was  observed  in tissues  exhibiting
intense  riboprobe  hybridization,  indicating  a good  correlation  between  receptor  transcription  and  trans-
lation.  While  the distribution  of APJ  mRNA  and  functional  protein  in  the  mouse  shows  similarities  to  that
of the  rat, we  report  a species  difference  in  central  APJ distribution  and  in the pituitary  gland.. Introduction
The recently described 36-amino acid peptide apelin [50] is
ssociated with multiple biological actions in both the central ner-
ous system (CNS) and in the periphery. In the CNS, apelin induces
ffects consistent with the regulation of body ﬂuid homeostasis and
tress responses [32,33,39],  and also of cardiovascular [21] and cen-
ral blood control [19]. In the periphery, the peptide is one of the
ost potent endogenous inotropic substances yet identiﬁed [49],
nd may  modulate pulmonary function [22]. Unlike most other
PCR families apelin appears to mediate its effects via binding to
nly one receptor subtype, the previously orphaned apelin receptor
APJ). The APJ gene has a number of other aliases including APLNR,
GTRL1, APJR and FLJ90771, while the International Union of Phar-
acology has recently recommended “apelin receptor” as the
omenclature for the receptor protein [37]. The cDNA sequences for
uman, mouse and rat APJ have been determined [10,34,36].  Rat APJ
ncodes a 377 amino acid polypeptide with a 96% and 89.7% over-
ll amino acid identity with the mouse and human APJ respectively
34]. Other isoforms of the apelin peptide, including apelin-13 and
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the pyroglutamyl form of apelin-13 ([Pyr1]apelin-13), bind to and
activate APJ and exhibit greater biological potency than the full-
length peptide in vivo [50], yet in human cardiovascular tissues all
three forms of apelin have comparable potency and efﬁcacy [29].
The apelinergic system has a widespread expression and to
date anatomical distribution studies have predominantly been
conducted in the rat (see Table 1 for summary). Rat APJ mRNA distri-
bution has been investigated using numerous techniques including
in situ hybridization histochemistry (ISHH), Northern blots and
reverse transcriptase-polymerase chain reaction (RT-PCR), with the
strongest signals apparent in the lung and heart and lower levels
evident in the brain hypothalamus and cerebroventricular region,
pituitary gland, skeletal muscle, kidney, spinal cord, thyroid gland,
adipose tissue, ovary and uterus [9,17,30,34]. Similarly, RT-PCR
studies have shown widespread APJ mRNA expression in human
tissues; high APJ expression was observed in human spleen, pla-
centa, spinal cord and corpus callosum with lower levels present
in the hypothalamus, hippocampus, lung, intestine, and stomach
[30]. In contrast, quantitative real-time polymerase chain reaction
(qPCR) studies in adult mouse tissues have shown APJ mRNA to be
Open access under CC BY license.present in the pituitary, heart, lung, ovary, and uterus, with low
expression levels in samples of whole brain and individual regions
[30,41].
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Table 1
Distribution of APJ mRNA and I125[Pyr1]apelin-13 binding/protein in mouse and rat tissues. Mouse data is relative distribution of APJ mRNA and I125[Pyr1]apelin-13 binding
in  the mouse. Analyses were made on four male and four female mice. Presented data is the subjective judgment of two  observers. No apparent gender differences were
detected. Rat data is consolidated from the following quantitative and semi-quantitative sources [9,10,16,17,22,29,30,53] using ISHH; Northern blot; RT-PCR; quantitative
real  time PCR; enzyme immuno-assay and immunohistochemistry.
Tissues Mouse Rat
APJ APJ Apelin
mRNA I125[Pyr1]apelin-13 binding mRNA Protein mRNA Protein
Brain −/+ −/+ + + ++ +
-PVN ++ ++ ++ ++ ND ND
-SON  ++ ++ ++ ND ND ND
Anterior pituitary +++ +++ ++/ + ++ ND +/ + +b +/ + +
Intermediate pituitary −/+ −/+ −/+ ND +/ + +b −
Posterior pituitary ++ −/ + + −/+ ND +/ + +b ++
Thymus −/+  + − ND ND ND
Lung +++ ++/+++ +++ ++ ++/+++ +++
Heart +++ +++ ++/+++ +/++ +/+++ +
Liver  − − − ND −/+ +
Adrenal gland +++a +++a ++ ND −/+ +
Kidney +/+++ +/+++ +/++ ND +/++ +
Pancreas − − + ND − +
Spleen −/+ −/+ − ND − +
Stomach + + + + +/+++ +/++
Intestine ++ ++/+++ + + −/+ +
Bladder + + −/+  ND − ND
Colon + + + + −/+ +
Ovary +++ +++ +/+++ + ++ +
Uterus +++ +++ +/++ + −/+ +
Mammary gland −/+ ++ +/++ +++ +++ +++
Testes − − − + +/++ ++
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a +++ expression only in adrenal cortex.
b Cumulative presence from analysis of whole pituitary.
Limited distribution studies of APJ protein have been carried out
o date. In the rat brain APJ protein expression was identiﬁed using
mmunohistochemistry (IHC) in the frontal and piriform cortices,
he PVN, the pyramidal CA2 and CA3 cell layer of the hippocampus,
entate gyrus, spinal cord and cerebellum [9].  APJ immunoreac-
ivity (APJ-ir) has also been shown in the SON and magnocellular
asopressin and oxytocin neurones of the pituitary [51] and in
ndothelial cells lining small intramyocardial, renal, pulmonary
nd adrenal vessels, small coronary arteries, large conduit vessels,
nd endocardial endothelial cells [21,24].
The regional localization and distribution of APJ led to fur-
her work clarifying the functions of this receptor. Thus high APJ
xpression in regions such as the heart and hypothalamic PVN and
ON led to investigation of roles for APJ in the cardiovascular sys-
em and in the regulation of water balance and stress responses
8,21,27,31,49]. Recent studies have employed apelin- and/or APJ-
nockout (KO) mice to further investigate the signiﬁcance of the
pelinergic system in cardiovascular function [19,25] and in ﬂuid
omeostasis [42,43]. APJ KO mice lack the hypotensive response
o peripherally injected apelin that is seen in wild type littermates
19] and show a signiﬁcant reduction in exercise capacity follow-
ng exercise stress [8],  suggesting roles for APJ in blood pressure
egulation and cardiac function, respectively. Additionally APJ KO
ice show abnormal water metabolism, manifested by a change
n drinking behavior and in the ability to concentrate urine [42],
nd an altered response to the osmotic stress of salt loading [43]
ompared with wild type littermates, suggesting that APJ is an
mportant regulator of mechanisms controlling ﬂuid homeosta-
is. Furthermore apelin KO mice display an aging- and pressure
verload-associated reduction in cardiac contractility [25] that sup-
orts the cardiovascular role of the apelinergic system. However (as
llustrated in Table 1), while APJ is relatively well characterized in
he rat it is not well described in an anatomical context in mouse
issues thus precluding correlations with function in these stud-
es. Greater understanding of the distribution of APJ in the mouselished data on distribution.
will allow better insight and interpretation of results (describ-
ing function of the apelinergic system) from apelin- and APJ-KO
mice. The aim of the present study was to provide an anatomi-
cal distribution of APJ mRNA and I125[Pyr1]apelin-13 binding sites
in mouse brain and peripheral tissues to (1) determine whether
mRNA encoding APJ corresponds to detectable functional protein
(i.e. APJ processed and folded correctly to allow iodinated agonist
binding); (2) determine whether there are species differences in
APJ mRNA/protein expression between the mouse and rat; and (3)
identify high expressing tissues in the mouse that may  provide an
anatomical basis for further experiments and understanding of the
functions mediated by APJ and its cognate ligand. To date, no radi-
olabeled ligand has been used to comprehensively map  the tissue
distribution of APJ in any species. We  have therefore used ISHH
with riboprobes speciﬁc for the mouse APJ to detect APJ mRNA dis-
tribution and autoradiography with I125[Pyr1]apelin-13 to reveal
apelin binding site localization.
2. Materials and methods
2.1. Animals
Male and female wildtype mice (8–14 weeks old, n = 6) from our
APJ KO colony (a mix  of the C57BL/6 and 129X1/SvJ strains) were
used in this study [31,42]. Animals were housed under constant
temperature (21 ± 2◦C), light (lights on from 0700 to 1900 h) and
humidity (45–50%) regimens with food and water ad libitum. Ani-
mal  care and maintenance were performed in accordance with the
Animal Scientiﬁc Procedures Act (1986) United Kingdom and the
appropriate University of Bristol ethical review process.2.2. In situ hybridization histochemistry (ISHH)
Sections (12 m)  of tissue were cut, thaw-mounted onto poly-
lysine-coated slides (VWR, Lutterworth, UK) and stored at −80 ◦C
tides 
u
1
p
C
A
A
g
a
s
m
p
p
M
i
i
S
a
(
d
g
w
d
D
w
2
o
d
d
i
A
7
C
H
S
o
E
b
B
o
i
a
p
1
a
H
e
m
o
w
3
3
t
p
w
l
l
t
tG.R. Pope et al. / Pep
ntil hybridization. All riboprobes were generated by PCR using
29sv genomic DNA as the template. For the mouse APJ 35S ribo-
robe primers (up-stream 5′-GCC CGA ATT CAC TTC ATT CAG CAC
AT GGA AGA T-3′; downstream 5′-GTC AGG ATC CCG GTA GGT ATA
GT GGC CCA CAG T-3′) corresponding to bp 256–549 of a mouse
PJ cDNA (Genbank Accession number NM011784) were used to
enerate a 293 bp product. Primer restriction endonuclease sites
llowed subcloning into pGEM4Z (Promega, Southampton, UK), and
ense and antisense probes were generated using T7 and SP6 poly-
erases (antisense: linearized with EcoRI and generated with T7
olymerase; sense: linearized with HindIII and generated with SP6
olymerase) with 35S-UTP (Perkin Elmer, Cambridge, UK) and the
AXIscript in vitro transcription kit (Ambion, Huntingdon, UK). The
ntegrity of each probe was veriﬁed by DNA sequencing.
Hybridization was carried out as described previously (http://
ntramural.nimh.nih.gov/lcmr/snge/Protocols/ISHH/ISHH.html).
lides were exposed to Amersham Hyperﬁlm MP  ﬁlm for 2 months
t room temperature with appropriate 14C-labeled standards
Amersham, Little Chalfont, UK). No speciﬁc hybridization was
etected with sense probes and no APJ mRNA signal above back-
round was detected in tissues from APJ KO mice. Some slides
ere subsequently dipped in Ilford K5 nuclear emulsion and stored
esiccated at 4 ◦C for 4–6 months before development using Kodak
19 at room temperature. Tissue sections were counterstained
ith toluidine blue.
.3. Receptor autoradiography
Mouse cryostat sections (20 m)  were cut and thaw mounted
nto subbed (gelatin, vanadium oxide) slides. APJ receptor autora-
iography was performed with modiﬁcations of the procedure
escribed by Katugampola et al. [21]. Brain sections were ﬁxed
n 0.1% PFA in PBS for 5 min  and rinsed in 10 mM Hepes pH 7.5.
ll sections were pre-incubated for 20 min  in 20 mM Hepes pH
.5 containing 1 mM EDTA, 0.3% BSA and Sigma Protease Inhibitor
omplex (Sigma, Dorset, UK). Slides were then incubated in 20 mM
epes, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 10 mM KCl, 1 mM EDTA,
igma protease inhibitor complex and 0.3% BSA containing radi-
labeled (Glp65, Nle75, Tyr77) (125I)-Apelin-13 [0.5 nM]  (Perkin
lmer, Cambridgeshire, UK) in the absence or presence of unla-
eled (Pyr1)-apelin-13 [1 M]  (Bachem, Germany) as a displacer.
inding speciﬁcity was assessed by comparison of the distribution
f [125I]-(Pyr1)apelin-13 binding sites in wildtype tissue to that
n APJ KO tissue. Incubation lasted 1 h at RT in a humid chamber
nd was followed by 2 × 10 min  washes in ice-cold 20 mM Hepes
H 7.5, 0.3% BSA with stirring and 2 × 15 min  washes in ice-cold
0 mM Hepes pH 7.5. Slides were then rinsed in ice-cold dH2O and
ir-dried at 4 ◦C before being exposed to X-ray ﬁlm (Amersham
yperﬁlm MP)  for 2 weeks. Following this some slides were re-
xposed to emulsion-coated ﬁlm (Amersham Hyperﬁlm 3H) for 1
onth to obtain better macroscopic resolution. Films were devel-
ped as described for ISHH, except emulsion-coated ﬁlms, which
ere developed manually as per manufacturer’s instructions.
. Results
.1. APJ mRNA distribution in the mouse
ISHH with antisense APJ riboprobes was used to map  the dis-
ribution of APJ mRNA in the male and female mouse brain and
eripheral tissues. Sections from all tissues were also hybridized
ith sense APJ riboprobes as controls and showed only backgroundevel of labeling. A number of tissues, including the pituitary,
ung, heart, ovary and uterus, showed high levels of hybridiza-
ion, with representative photographs shown in Figs. 1–3.  Within
he brain APJ mRNA had a very restricted distribution where the33 (2012) 139–148 141
PVN and SON hypothalamic regions showed high levels of gene
expression (Fig. 1A and B). No labeling of other structures through-
out the brain was  observed. Within the other components of the
hypothalamic–pituitary–adrenal (HPA) axis, the pituitary gland
showed high to moderate expression of APJ mRNA in the anterior
and posterior lobes respectively, where expression was  found in
scattered cells with some sparse signal in the intermediate lobe
(Fig. 1C–E). The cortex of the adrenal gland also showed prominent
hybridization of the three cortical zones with no expression seen
in the medulla (Fig. 1F and G).
In the kidney a high level of APJ expression was  seen in the
medulla, speciﬁcally the inner stripe of the outer medulla, con-
sistent with hybridization to the medullary rays, with patch-like
labeling observed in the outer cortex that may  correspond to tubu-
lar structures (e.g. distal/proximal tubule) (Fig. 2A). No labeling was
seen in the glomeruli. In the lung, APJ mRNA was restricted to the
parenchyma (Fig. 2B) and there was  no evidence of any association
with the lining of blood vessels or in the bronchi or bronchioles. In
the pyloric region of the stomach the mucosal layer of the stomach
lining showed a strong hybridization signal for APJ (Fig. 2C) with
transcript also seen within the villi of the ileum (Fig. 2D). Hybridiza-
tion within the heart was widespread with APJ expression present
in cardiomyocytes throughout the myocardium (Fig. 2E). No signal
was observed in heart sections hybridized with sense probe (inset),
similarly no APJ mRNA signal was detected in heart tissue from APJ
KO mice (Fig. 2F).
Moderate hybridization levels were present in the uterine
endometrial lining, however no signal was  detected in the
myometrium (Fig. 3A). In the ovary (Fig. 3B), the theca cells sur-
rounding the antral follicles showed intense labeling (Fig. 3B and
C) as did the cells of the corpus luteum (Fig. 3B), while no signal
was present in ovary sections hybridized with sense probe (Fig. 3B,
inset) and only background levels of radiolabeling were detected
in the ovary of APJ KO mice (Fig. 3D).
APJ mRNA, as indicated by the presence of hybridization sig-
nal, was  not detected in a number of other tissues including liver,
spleen, gall bladder, thymus, trachea, pancreas and testis (images
not shown). The pattern of APJ mRNA expression was similar
between male and female mice. The data is summarized in Table 1.
3.2. Receptor autoradiography
[125I]-(Pyr1)apelin-13 was used to localize APJ binding sites in
the mouse brain and peripheral tissues. Binding speciﬁcity was
assessed by binding of radiolabeled apelin-13 in the presence of
1 M unlabeled (Pyr1)apelin-13 and by comparison of APJ distri-
bution in wildtype mouse tissue to that in APJ KO tissues, where
no speciﬁc binding was observed in any tissue. Of note, while APJ
binding corresponds to correctly processed and folded receptors it
does not unquestionably infer that the receptors present are capa-
ble of signaling. In agreement with our localization results obtained
using ISHH in wildtype mice, strong binding of [125I]-(Pyr1)apelin-
13 was  observed in the pituitary, lung, heart, adrenal gland, ovary
and uterus, indicating high expression of APJ, with lower densi-
ties in the brain and bladder, while no binding was in seen in the
liver, pancreas and testis. In the hypothalamus binding was local-
ized to the PVN and SON (Fig. 4A). No binding of other structures
throughout the brain was  observed. High densities of APJ were
present in the anterior lobe of the pituitary with moderate lev-
els of binding sites seen in the posterior lobe. Little to no binding
above background levels was seen in the intermediate lobe (Fig. 4B).
[125I]-(Pyr1)apelin-13 binding was  also seen in the adrenal cortex
with the highest receptor densities seen in the zona glomerulosa
and no APJ binding sites were found in the medulla (Fig. 4C). No
binding was  detected in the adrenal gland in the presence of unla-
beled ligand (inset Fig. 4C).
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Fig. 1. Localization of APJ mRNA in the HPA axis of the adult mouse by ISHH. Low magniﬁcation images of autoradiographic ﬁlms showing slide mounted tissue sections
hybridized with an antisense 35S-labeled APJ riboprobe. (A) Labeling of the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei; (B) shows bright-ﬁeld high
power micrographs of APJ mRNA distribution within the mouse PVN. (C) Signal is present in populations of cells in the anterior lobe (al) and posterior lobe (pl) of the pituitary,
however very few cells expressing APJ mRNA were detected in the intermediate lobe (il); (D) and (E) are bright-ﬁeld high power micrographs of APJ mRNA distribution
in  the anterior and posterior lobes of the pituitary, respectively. (F) In the adrenal gland strong signal is seen in all regions of the cortex (c) with no signal detected in the
medulla (m). Image from corresponding sense 35S-labeled APJ riboprobe in mouse adrenal gland is shown (inset); (G) shows bright-ﬁeld high power micrographs of APJ
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In the kidney the most dense localization of [125I]-(Pyr1)apelin-
3 binding sites was found in the outer medulla with patches
f binding found in the cortex (Fig. 5A). The lung showed uni-
orm binding to the parenchyma with no binding sites detected
n connective tissue or blood vessels (Fig. 5B). High densities of
PJ binding sites were localized to the mucosal layer of the pyloric
egion of the stomach (Fig. 5C) as well as in the mucosa and villi of
he ileum (Fig. 5D). The density of APJ binding sites in the heart was
niform throughout the myocardium (Fig. 5E). No speciﬁc binding
as detected in the presence of unlabeled ligand (Fig. 5E, inset) not
n the heart of APJ KO mice (Fig. 5F).
In the uterus very high levels of binding were present in the
ndometrium but totally absent from the myometrium (Fig. 6A).
he ovary displayed strong binding in the theca cells of follicles
nd in corpus lutea (Fig. 6B) while no binding occurred in the pres-
nce of unlabeled (Pyr1)apelin-13 (Fig. 6B, inset), Speciﬁc labeling
f (Pyr1)apelin-13 binding sites was absent in the APJ KO ovary
Fig. 6C).
. Discussion
Previous studies mapping APJ distribution have focused primar-
ly on APJ mRNA expression in rat brain and peripheral tissues and
ew studies have investigated the distribution of APJ protein in any
pecies. The present study provides the ﬁrst detailed characteriza-
ion of APJ mRNA and I125[Pyr1]apelin-13 binding site distribution
n the mouse. We  have found that APJ mRNA and I125[Pyr1]apelin-
3 binding site localization appear to be unaffected by gender and
hat there is a clear correlation between the expression of APJ B, D, E and G equal 100 m.
mRNA and I125[Pyr1]apelin-13 binding. A summary of our ﬁndings
is shown in Table 1.
4.1. CNS
We report a restricted localization of both APJ mRNA and
I125[Pyr1]apelin-13 binding sites in the mouse CNS, with discern-
able levels found only in the hypothalamic PVN and SON. While
we cannot discount that the level of APJ in additional regions of
the mouse CNS is too low to allow detection by the techniques
used in our study, comparable studies in rats have revealed high
levels of APJ mRNA in the cerebroventricular system, hypothala-
mus, the pineal gland, olfactory bulb and hippocampus [9,17,34],
suggesting a species difference in central APJ distribution. Further-
more, RT-PCR studies on human samples conﬁrm the widespread
APJ mRNA expression in the CNS, with highest levels in the spinal
cord and corpus callosum and with lower expression detected
in the hypothalamus and hippocampus [30]. The central ape-
linergic system in rats appears to be involved in cardiovascular
regulation [20] and activation of the arcuate POMC network [40].
It also appears to protect the hippocampus from excitotoxicity,
including that induced by human immunodeﬁciency virus type I
[35]. In mice, immediate early gene expression in the subfornical
organ, median preoptic nucleus and PVN in response to pertur-
bations in water homeostasis is altered in APJ-KO mice [42,43].
In addition, central apelin administration in mice increases CRF-
and VP-induced ACTH secretion [31], regulates energy homeosta-
sis [11,52], inhibits gastric emptying and gastrointestinal transit
[28] and has antinociceptive effects [54]. Many of these central
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Fig. 2. Localization of APJ mRNA in the peripheral tissues of the adult mouse by ISHH. Low magniﬁcation images of autoradiographic ﬁlms of slide-mounted tissue sections
hybridized with an antisense 35S-labeled APJ riboprobe. (A) The kidney exhibits labeling in the outer cortex (c) and the medulla (m). (B) In the lung there is strong labeling
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bhroughout the parenchyma. (C) The pyloric region of the stomach is shown with s
igher  magniﬁcation, speciﬁc labeling in the villi (v) and mucosa (mm)  of the ileu
ense 35S-labeled APJ riboprobe shown (inset). (F) An absence of signal was observeffects are thought to be mediated at the level of the hypothala-
us. The functional signiﬁcance of the apparent species differences
n the central expression of APJ mRNA is not known. Profound
pecies differences in central GPCR expression is not uncommon
ig. 3. Localization of APJ mRNA in the periphery of the adult mouse by ISHH. Low magniﬁ
ith  an antisense 35S-labeled APJ riboprobe. (A) Labeling of cells of the endometrial laye
n  an ovary, with follicle (f) and corpus luteum (cl) indicated, with sense 35S-labeled APJ r
ipped  section showing APJ mRNA distribution within a follicle. (D) APJ KO ovary with fol
ar  in C equals 100 m.c labeling in the mucosa muscularis (mm) and the duodenum indicated (d). (D) At
bserved. (E) Labeling in the heart atrium (a) and ventricle (v) with corresponding
he APJ KO heart atrium (a) and ventricle (v). All scale bars equal 1 mm.– a striking example is the pattern of oxytocin and VP receptor
expression in rodents [3] which may  provide the anatomical sub-
strates for species differences in the expression of social behavior.
There appear to be differences in the meningeal and hippocampal
cation images of autoradiographic ﬁlms of slide mounted tissue sections hybridized
r of the uterus (ed) with no labeling of the myometrium (my). (B) Labeling present
iboprobe shown (inset); (C) is a brightﬁeld high power micrograph of an emulsion
licle (f) and corpus luteum (cl) indicated. Scale bars in A, B and D equal 1 mm,  scale
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Fig. 4. Representative autoradiographical localization of 125I-[Pyr1]apelin-13 bind-
ing in the HPA axis of the adult mouse. (A) Individual sections displaying speciﬁc
binding of 125I-[Pyr1]apelin-13 (0.5 nM)  in the hypothalamic PVN and SON. (B) The
anterior pituitary (ap) is heavily labeled, with moderate levels of binding localized to
the  posterior lobe (pl) and non-speciﬁc levels seen in the intermediate lobe (il). (C)
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ghe cortex (c) of the adrenal gland displays strong binding with the highest density
een  in the outer zona glomerulosa (zg) with an absence of speciﬁc binding sites in
he presence of [1 M]  unlabeled (Pyr1)apelin-13 (inset). All scale bars equal 1 mm.
xpression of APJ between mice and rats (e.g., see Fig. 2 in Hazell
t al. [16]). As APJ can potentially act as a co-receptor for viruses in
on-immune cells [38,46],  one intriguing possibility is that species
r strain differences in meningeal cell and hippocampal APJ expres-
ion levels may  inﬂuence the susceptibility to certain microbes and
ontribute to neuroprotection, respectively.
.2. Pituitary
In the pituitary gland of the mouse high to moderate APJ mRNA
xpression was observed in cells of the anterior and posterior lobes
espectively with only sparse labeling in the intermediate lobe. This
iffers from the rat with reports of a moderately strong distribu-
ion of APJ mRNA in the anterior lobe but not in the posterior or
ntermediate lobes [34]; or as shown by De Mota and co-workers
9],  APJ mRNA expression in the anterior and intermediate lobes
ut not in the posterior lobe of the rat pituitary. In contrast APJ-ir
as been found in the nerve terminals of the rat posterior pituitary
land [51]. Our study in mice suggests that APJ mRNA is present33 (2012) 139–148
in an unidentiﬁed posterior pituitary cell type that may  be resi-
dent pituicytes or glial cells where other GPCRs including the V1a
receptor are known to be expressed and speculated to indirectly
inﬂuence neurohypophysial hormone release [15]. The extent of
APJ binding sites, i.e. widespread rather than restricted to scat-
tered cells, could suggest that APJ is expressed in both cells and
nerve terminals in the mouse posterior pituitary. The SON and
PVN are well-known integrative sites that regulate coordinated
responses to osmotic stressors. Vasopressin, along with oxytocin, is
synthesized primarily within these neurones, which project their
axons from hypothalamic cell bodies to terminals on the capillar-
ies of the posterior pituitary neural lobe to release the peptides
into the systemic circulation. Hormone release studies from iso-
lated rat SON and neural lobes in vitro show signiﬁcantly decreased
basal vasopressin release from SON but not from neural lobe prepa-
rations after apelin administration, indicating a possible role for
apelin in dendritic rather than axonal vasopressin release [51]. The
species difference in APJ distribution seems likely to reﬂect a more
extensive role for apelin in mouse pituitary function to regulate
neurohypophysial hormone release.
4.3. Adrenal gland
In the mouse adrenal gland APJ mRNA and I125[Pyr1]apelin-13
binding sites were expressed throughout the cortex, with little to
no presence in the medulla. This is the ﬁrst reported detailed dis-
tribution of APJ expression within the rodent adrenal gland, with
no described function to date. The localization however, points
to a possible role of APJ and its cognate ligand in corticosteroid
release. In contrast to the mouse distribution, in human adrenals
APJ-ir is conﬁned to endothelial cells of the surrounding arteries,
small resistance arteries within the capsular plexus and the central
vein while APJ-ir was not detectable in secretory cells of either the
adrenal cortex or medulla [23].
4.4. Kidney
APJ mRNA and I125[Pyr1]apelin-13 binding sites were present
throughout mouse renal cortex and medulla, however APJ expres-
sion was  not integral to the glomeruli as previously reported in
the rat [34], a localization that was suggestive of a role for this
receptor in the regulation of blood ﬂow or glomerular ﬁltration.
Expression in the mouse was  associated with the renal corpuscle,
similarly signal was observed in sporadic cells along proximal and
distal tubules although a speciﬁc association with blood vessels or
collecting ducts, as has been seen previously in the rat [18], was
not observed. The low resolution of APJ mRNA on autoradiographic
ﬁlms of the kidney does not allow us to clarify morphologically the
exact cell types in the kidney within which mouse APJ expression is
localized. APJ mRNA has also been identiﬁed in mouse kidney using
RT-PCR [30]. The role of apelin in the kidney is unclear however
strong expression of APJ mRNA and high levels of I125[Pyr1]apelin-
13 binding suggests an involvement of peripheral aspects of the
apelinergic system in the regulation of ﬂuid homeostasis as has
been suggested by studies in the APJ KO mouse [42,43],  while
APJ expression in the highly vascularized inner stripe of the outer
medulla suggests a possible renal medullary microcirculatory role
for the mouse receptor. In the human APJ mRNA expression is found
in the kidney [30], while in sections from human kidney APJ-ir is
present in endothelial cells and in vascular smooth muscle cells of
small intrarenal vessels [23].4.5. Lung
In the lung APJ mRNA was detected in the parenchyma as pre-
viously described in the rat [10], while unlike recent reports of APJ
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Fig. 5. Representative autoradiographical localization of 125I-[Pyr1]apelin-13 binding in peripheral tissues of the adult mouse. (A) In the kidney low concentrations of 125I-
[Pyr1]apelin-13 binding sites are present in the cortex (oc) and high densities of APJ in the medulla (m). (B) Binding to lung parenchyma (C) The pyloric region of the stomach
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mm).  (E) The heart, atria (a) and ventricles (v) show strong binding to APJ, with la
peciﬁc receptor binding sites in the APJ KO heart atrium (a) and ventricle (v). All sc
istribution in the rat, there was no evidence of expression in the
ining of pulmonary blood vessels [1].  Additionally no expression
as seen in endothelial and vascular smooth muscle cells from
mall pulmonary vessels as reported for rat and human lung [24].
he strong expression of APJ in the lung suggests that it plays a
igniﬁcant, though yet undescribed, role in pulmonary function
.6. Stomach and intestine
APJ mRNA distribution in the mouse stomach was predomi-
antly within the glandular region and ‘body’ of stomach, not the
ore stomach, in agreement with RT-PCR results reported in the
at by Hosoya and co-workers [17]. In the intestine, APJ mRNA
nd I125[Pyr1]apelin-13 binding sites are localized to the mucosa
nd more evidently to the villi. Apelin has previously been shown
o stimulate the secretion of cholecystokinin (CCK), responsible
or stimulating the digestion of fat and protein, from a murine
mall-intestinal cell line (STC-1) [53], and to be present in lumi-
al perfusate of the rat intestine. While CCK cells are present in
he duodenum and jejunum of the intestine [26], APJ has not been
ocalized to CCK cells. However, these recent studies suggest that
PJ may  be found on CCK cells, facilitating apelin stimulation of CCK
ecretion [53].
.7. Heart
In our study in situ hybridization signal and receptor binding
ithin the mouse heart were widespread, with APJ expression
ound predominantly throughout the myocardium with minimal
ignal associated with vessels. A high level of APJ mRNA expres-
ion was detected by quantitative RT-PCR in the rat heart [17] ande ileum shows strong binding in the villi (v) and to a lesser extent in the mucosa
inding in the presence of [1 M]  unlabeled (Pyr1)apelin-13 (inset). (F) Absence of
rs equal 1 mm.
these ﬁndings were conﬁrmed by Northern blot analysis and ISHH
[34]. APJ has been detected in rat and human myocardium as well
as in the medial layer of human coronary artery, aorta and saphe-
nous vein using radioligand binding [51], and APJ-ir is present in
endothelial cells, vascular smooth muscle cells and cardiomyocytes
[30]. Recent studies indicate a role for the apelin–APJ signaling
pathway in basic cardiac function and during the development of
hypertension and there is growing evidence that apelin may  be
involved in the transition from compensated hypertrophy to clin-
ically signiﬁcant heart failure [12]. Apelin may  therefore act as a
cardiovascular regulator in the human and rat, and it has been
shown to have a sustained positive inotropic effect on intact rat
hearts [2,4,49], with a more transient effect observed in ex vivo
myocytes [13]. Thus, expression of APJ transcripts and protein in
the mouse cardiomyocytes supports the proposed cardiovascular
effects of apelin.
4.8. Uterus and ovary
High levels of APJ mRNA and I125[Pyr1]apelin-13 binding sites
were detected throughout the mouse uterine endometrium. There
was no evidence of APJ expression within endometrial glands or in
the myometrium, consistent with APJ mRNA distribution in the rat
uterus [34]. In agreement with these ﬁndings a comparatively high
level of APJ mRNA expression was detected by quantitative RT-PCR
in the mouse uterus when compared with rat and human tissue
[17].In the mouse ovary APJ mRNA and I125[Pyr1]apelin-13 binding
were predominantly associated with theca cells surrounding antral
follicles. APJ was  not localized around primary follicles, nor associ-
ated with the major vasculature within the interstitium. Numerous
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Fig. 6. Representative autoradiographical localization of 125I-[Pyr1]apelin-13
binding in peripheral tissues of the adult mouse. (A) Speciﬁc binding of 125I-
[Pyr1]apelin-13 (0.5 nM) in the uterine endometrium (ed) and (B) the follicle (f)
and corpus luteum (cl) of the ovary, with an absence of binding in the ovary in the
presence of [1 M] unlabeled (Pyr1)-apelin-13 (B inset). (C) Absence of binding in
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suggests however that the apelin/APJ system may  have a morehe  APJ KO ovary follicle (f) or corpus luteum (cl). Myometrium (my). All scale bars
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poradic cells with a very dense expression of APJ mRNA were
ocated throughout the interstitium. The corpus luteum had a high
evel of expression of APJ – the pattern of expression is consis-
ent with the distribution of the theca lutein cells formed from
he theca-interna following rupture of the follicle. In the rat ovary
ntense labeling was observed in cells located toward the periph-
ry of the corpora lutea mass and in some theca and stromal cells
urrounding large antral follicles, while granulosa and theca cells
f small antral follicles, theca lutein and interstitial cells did not
xpress APJ mRNA [34]. APJ and apelin mRNAs have a distinct but
verlapping distribution in the rat ovary. All corpora lutea express
igh levels of APJ mRNA but not all APJ mRNA expressing corpora
utea contain apelin mRNA (O’Carroll, unpublished observation) –
hether this is related to the stage of the corpora lutea (e.g. new
r regressing) has not been established. The distribution of mRNA
ncoding APJ and apelin within the ovary is suggestive of a role
or apelin as a novel modulator of ovarian function. The expres-
ion of both apelin and APJ mRNAs in some corpora lutea and
heca cells suggests that the intraovarian apelin system may  have33 (2012) 139–148
an autocrine role. In addition, a paracrine action of apelin is sup-
ported by the demonstration of both apelin and APJ gene expression
within the same subset of luteal cells [47]. In particular, the promi-
nent localization of the apelin/APJ system in corpora lutea suggests
that it may  participate in luteolysis, vascularization and/or regres-
sion/apoptosis within this compartment. Data from bovine ovary
suggest that apelin/APJ system is involved in the mechanism reg-
ulating angiogenesis during follicle maturation as well as during
corpora lutea formation [44] and there is also evidence of APJ and
apelin in theca and granulosa cells participating in follicular atresia
[45].
Apelin has been found to have as extensive a distribution as APJ
and in all of the tissues examined in this study, where we have
found the greatest expression of APJ in the mouse, apelin has also
been reported to be present. In regions such as the PVN/SON and
the anterior and posterior lobes of the pituitary apelin distribution
is very similar to that of APJ [6,22,27,30]. Studies on apelin distribu-
tion in peripheral tissues are limited, with whole tissue distribution
studies exhibiting high levels of apelin in mouse lung, heart, kid-
ney and ovary [30]. Such matched distributions could indicate
the presence of autocrine or paracrine signaling systems in these
tissues.
No expression of APJ transcript or I125[Pyr1]apelin-13 bind-
ing was observed in a number of mouse tissues including liver
and pancreas. Using RT-PCR however, APJ mRNA has been iden-
tiﬁed in mouse and human liver and pancreas [30,41,48].  Apelin
has been identiﬁed as a novel adipokine, which is upregulated
by obesity and hyperinsulinemia in both humans and mice [5,7].
Expression of APJ in mouse islets has been reported where apelin-
36 inhibited glucose-stimulated insulin secretion both in vivo
and in vitro [48] suggesting a link between this adipokine and
glucose homeostasis. Thus, apelin may  be involved in the regu-
lation of islet function, although its precise role remains to be
established.
Additionally the ﬁnding that APJ is not expressed in mouse testis
is intriguing as moderate levels of apelin mRNA are found in this
tissue [14]. This lack of testicular APJ conﬁrms previous ﬁndings in
the rat by us [34] and others [17,30] using RT-PCR, but differs from
other RT-PCR studies showing expression in human and mouse
testis [30]. It is possible that testicular APJ is developmentally reg-
ulated since APJ mRNA expression appears to be higher in infant
compared to adult peripheral tissues [17].
In this study we  provide the ﬁrst detailed characterization of APJ
distribution in the mouse and report a clear correlation between
mouse APJ transcription and translation. The APJ expressing tissues
in the mouse where potential functional correlations are identiﬁed
are the brain, heart, pituitary gland and adrenal gland. Expression
was also observed in kidney, lung, stomach, uterus and ovary and
no expression of APJ transcript or I125[Pyr1]apelin-13 binding could
be observed in a number of tissues including liver and pancreas. We
cannot discount the possibility that low levels of (possibly rapidly
turning-over) APJ mRNA are below the detection threshold of ISHH,
which may  be detected with more sensitive methods such as RT-
PCR, however it must be stressed that the functional signiﬁcance of
low levels of mRNA as detected by RT-PCR in the CNS or peripheral
tissue samples is unknown. There appears to be a species differ-
ence in central APJ distribution and in the pituitary gland, with a
widespread central APJ distribution in the rat compared to a more
restricted distribution seen in the mouse, while APJ distribution
in peripheral tissues appears to be comparable between rat and
mouse. The functional signiﬁcance of the apparent species differ-
ences in the central expression of APJ mRNA is not known. Our studywide-ranging central role in the rat than the mouse, that should
be considered when drawing comparisons between studies in the
rat and APJ KO mice.
tides 
A
w
a
(
T
a
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[G.R. Pope et al. / Pep
cknowledgements
GRP is the recipient of a BBSRC PhD studentship. This work
as supported by The Wellcome Trust (Grant number 076321)
nd the Biotechnology and Biological Sciences Research Council
Grant number BB/D00196X/1) to A-MO’C and by The Wellcome
rust to SJL. There is no conﬂict of interest that could be perceived
s prejudicing the impartiality of the research reported.
eferences
[1] Andersen CU, Markvardsen LH, Hilberg O, Simonsen U. Pulmonary apelin lev-
els  and effects in rats with hypoxic pulmonary hypertension. Respir Med
2009;103:1663–71.
[2] Ashley EA, Powers J, Chen M,  Kundu R, Finsterbach T, Caffarelli A, et al. The
endogenous peptide apelin potently improves cardiac contractility and reduces
cardiac loading in vivo. Cardiovasc Res 2005;65:73–82.
[3]  Beery AK, Lacey EA, Francis DD. Oxytocin and vasopressin receptor distributions
in a solitary and a social species of tuco-tuco (Ctenomys haigi and Ctenomys
sociabilis). J Comp Neurol 2008;507:1847–59.
[4] Berry MF,  Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ, et al.
Apelin has in vivo inotropic effects on normal and failing hearts. Circulation
2004;110:187–93.
[5] Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli MJ,  et al. a
newly identiﬁed adipokine up-regulated by insulin and obesity. Endocrinology
2005;14:1764–71.
[6] Brailoiu GC, Dun SL, Yang J, Ohsawa M,  Chang JK, Dun NJ. Apelin-
immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett
2002;327:193–7.
[7] Castan-Laurell I, Vítkova M,  Daviaud D, Dray C, Kováciková M,  Kovacova Z,
et  al. Effect of hypocaloric diet-induced weight loss in obese women on
plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol
2008;158:905–10.
[8]  Charo DN, Ho MY,  Fajardo GA, Kawana M,  Kundu R, Sheikh AY, et al. Endogenous
Regulation of Cardiovascular Function by Apelin–APJ. Am J Physiol Heart Circ
Physiol 2009;297:H1904–13.
[9] De Mota N, Lenkei Z, Llorens-Cortes C. Cloning, pharmacological characteri-
zation and brain distribution of the rat apelin receptor. Neuroendocrinology
2000;72:400–7.
10] Devic E, Rizzoti K, Bodin S, Knibiehler B, Audigier Y. Amino acid sequence and
embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and
human APJ. Mech Dev 1999;84:199–203.
11] Duparc T, Colom A, Cani PD, Massaly N, Rastrelli S, Drougard A, et al. Central
apelin controls glucose homeostasis via a nitric oxide-dependent pathway in
mice. Antioxid Redox 2011;15:1477–96.
12] Falcão-Pires I, Gonc¸ alves N, Gavina C, Pinho S, Teixeira T, Moura C, et al.
Correlation between plasma levels of apelin and myocardial hypertrophy in
rats  and humans: possible target for treatment? Expert Opin Ther Targets
2010;14:231–41.
13] Farkasfalvi K, Stagg MA,  Coppen SR, Siedlecka U, Lee J, Soppa GK, et al.
Direct effects of apelin on cardiomyocyte contractility and electrophysiology.
Biochem Biophys Res Commun 2007;357:889–95.
14] Habata Y, Fujii R, Hosoya M,  Fukusumi S, Kawamata Y, Hinuma S, et al. Apelin,
the natural ligand of the orphan receptor APJ, is abundantly secreted in the
colostrum. Biochim Biophys Acta 1999;1452:25–35.
15] Hatton GI. Glial–neuronal interactions in the mammalian brain. Adv Physiol
Educ 2002;26:225–37.
16] Hazell GGJ, Hindmarch CC, Pope GR, Roper JA, Lightman SL, Murphy D, et al. G
protein-coupled receptors in the hypothalamic paraventricular and supraoptic
nuclei âD Serpentine gateways to neuroendocrine homeostasis. Front Neuroen-
docrinol 2011:1–22, doi:10.1016/j.yfrne.2011.07.002.
17] Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, et al.
Molecular and functional characteristics of APJ. Tissue distribution of mRNA
and  interaction with the endogenous ligand apelin. J Biol Chem 2000;275:
21061–7.
18] Hus-Citharel A, Bouby N, Frugière A, Bodineau L, Gasc JM, Llorens-Cortes C.
Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney
Int 2008;74:486–94.
19] Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, et al. Regula-
tory roles for APJ, a seven-transmembrane receptor related to angiotensin-type
1  receptor in blood pressure in vivo. J Biol Chem 2004;279:26274–9.
20]  Kagiyama S, Fukuhara M,  Matsumura K, Lin Y, Fujii K, Iida M.  Central and
peripheral cardiovascular actions of apelin in conscious rats. Regul Pept
2005;125:55–9.
21] Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP. [(125)I]-
(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor
in  human and rat tissues with evidence for a vasoconstrictor role in man. Br J
Pharmacol 2001;132:1255–60.
22] Kawamata Y, Habata Y, Fukusumi S, Hosoya M,  Fujii R, Hinuma S, et al. Molecular
properties of apelin: tissue distribution and receptor binding. Biochim Biophys
Acta 2001;1538:162–71.
[33 (2012) 139–148 147
23] Kleinz MJ, Davenport AP. Immunocytochemical localization of the endogenous
vasoactive peptide apelin to human vascular and endocardial endothelial cells.
Regul Pept 2004;118:119–25.
24] Kleinz MJ,  Skepper JN, Davenport AP. Immunocytochemical localisation of the
apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and
endothelial cells. Regul Pept 2005;126:233–40.
25] Kuba K, Zhang L, Imai Y, Arab S, Chen M,  Maekawa Y, et al. Impaired heart
contractility in Apelin gene-deﬁcient mice associated with aging and pressure
overload. Circ Res 2007;101:32–42.
26] Larsson LI, Rehfeld JF. Distribution of gastrin and CCK cells in the rat gas-
trointestinal tract. Evidence for the occurrence of three distinct cell types
storing COOH-terminal gastrin immunoreactivity. Histochemistry 1978;58:
23–31.
27] Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, et al. Characterization
of  apelin, the ligand for the APJ receptor. J Neurochem 2000;74:34–41.
28] Lv SY, Yang YJ, Qin YJ, Xiong W,  Chen Q. Effect of centrally administered
apelin-13 on gastric emptying and gastrointestinal transit in mice. Peptides
2011;32:978–82.
29] Maguire JJ, Kleinz MJ,  Pitkin SL, Davenport AP. [Pyr1]apelin-13 identiﬁed as the
predominant apelin isoform in the human heart: vasoactive mechanisms and
inotropic action in disease. Hypertension 2009;54:598–604.
30] Medhurst AD, Jennings CA, Robbins MJ,  Davis RP, Ellis C, Winborn KY,
et  al. Pharmacological and immunohistochemical characterization of the
APJ  receptor and its endogenous ligand apelin. J Neurochem 2003;84:
1162–72.
31] Newson MJ,  Roberts EM,  Pope GR, Lolait SJ, O’Carroll AM.  The effects of apelin
on  hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated
through corticotrophin-releasing factor- and vasopressin-dependent mecha-
nisms. J Endocrinol 2009;202:123–9.
32] O’Carroll A-M, Don AL, Lolait SJ. APJ receptor mRNA expression in the rat
hypothalamic paraventricular nucleus: regulation by stress and glucocorti-
coids. J Neuroendocrinol 2003;15:1095–110.
33] O’Carroll A-M, Lolait SJ. Regulation of rat APJ receptor messenger ribonucleic
acid expression in magnocellular neurones of the paraventricular and supraop-
tic  nuclei by osmotic stimuli. J Neuroendocrinol 2003;15:661–6.
34] O’Carroll A-M, Selby TL, Palkovits M,  Lolait SJ. Distribution of mRNA encoding
B78/apj, the rat homologue of the human APJ receptor, and its endoge-
nous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta
2000;1492:72–80.
35] O’Donnell LA, Agrawal A, Sabnekar P, Dichter MA, Lynch DR, Kolson D, et al. an
endogenous neuronal peptide, protects hippocampal neurons against excito-
toxic injury. J Neurochem 2007;102:1905–17.
36] O’Dowd BF, Heiber M,  Chan A, Heng HH, Tsui LC, Kennedy JL, et al. A human
gene that shows identity with the gene encoding the angiotensin receptor is
located on chromosome 11. Gene 1993;136:355–60.
37] Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. International Union of Basic
and Clinical Pharmacology LXXIV. Apelin receptor nomenclature, distribution,
pharmacology, and function. Pharmacol Rev 2010;62:331–42.
38] Puffer BA, Sharron M,  Coughlan CM,  Baribaud F, McManus CM,  Lee B, et al.
Expression and coreceptor function of APJ for primate immunodeﬁciency
viruses. Virology 2000;276:435–44.
39] Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, et al. Phys-
iological role of a novel neuropeptide, apelin, and its receptor in the rat brain.
J  Neurochem 2001;77:1085–96.
40] Reaux-Le Goazigo A, Bodineau L, De Mota N, Jeandel L, Chartrel N, Knauf
C,  et al. Apelin and the proopiomelanocortin system: a new regulatory
pathway of hypothalamic -MSH release. Am J Physiol Endocrinol Metab
2011;301:E955–66.
41] Regard JB, Sato IT, Coughlin SR. Anatomical proﬁling of G protein-coupled
receptor expression. Cell 2008;135:561–71.
42] Roberts EM,  Newson MJ, Pope GR, Landgraf R, Lolait SJ, O’Carroll AM.
Abnormal Fluid Homeostasis in apelin receptor knockout mice. J Endocrinol
2009;202:453–62.
43] Roberts EM,  Pope GR, Newson MJ,  Landgraf R, Lolait SJ, O’Carroll AM.  Stimulus-
speciﬁc neuroendocrine responses to osmotic challenges in apelin receptor
knockout mice. J Neuroendocrinol 2010;22:301–8.
44] Schilffarth S, Antoni B, Schams D, Meyer HH, Berisha B. The expression of apelin
and its receptor APJ during different physiological stages in the bovine ovary.
Int  J Biol Sci 2009;5:344–50.
45] Shimizu T, Kosaka N, Murayama C, Tetsuka M,  Apelin Miyamoto A. APJ recep-
tor  expression in granulosa and theca cells during different stages of follicular
development in the bovine ovary: Involvement of apoptosis and hormonal
regulation. Anim Reprod Sci 2009;116:28–37.
46] Shimizu N, Soda Y, Kanbe K, Liu HY, Mukai R, Kitamura T, et al. A putative G
protein-coupled receptor, RDC1, is a novel coreceptor for human and simian
immunodeﬁciency viruses. J Virol 2000;74:619–26.
47] Shirasuna K, Shimizu T, Sayama K, Asahi T, Sasaki M, Berisha B, et al. Expres-
sion  and localization of apelin and its receptor APJ in the bovine corpus luteum
during the estrous cycle and prostaglandin F2alpha-induced luteolysis. Repro-
duction 2008;135:519–25.
48] Sörhede Winzell M,  Magnusson C, Ahrén B. The APJ receptor is expressed in
pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice. Regul
Pept 2005;131:12–7.
49] Szokodi I, Tavi P, Földes G, Voutilainen-Myllyla S, Ilves M,  Tokola H,  et al. Apelin,
the  novel endogenous ligand of the orphan receptor APJ, regulates cardiac
contractility. Circ Res 2002;91:434–40.
1 tides 
[
[
[
[48 G.R. Pope et al. / Pep
50]  Tatemoto K, Hosoya M,  Habata Y, Fujii R, Kakegawa T, Zou MX,  et al. Isolation
and characterization of a novel endogenous peptide ligand for the human APJ
receptor. Biochem Biophys Res Commun 1998;251:471–6.
51] Tobin VA, Bull PM,  Arunachalam S, O’Carroll AM,  Ueta Y, Ludwig M.  The effects
of  apelin on the electrical activity of hypothalamic magnocellular vasopressin
and oxytocin neurons and somatodendritic peptide release. Endocrinology
2008;149:6136–45.
52] Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. Chronic central admin-
istration of apelin-13 over 10 days increases food intake, body weight,
[33 (2012) 139–148
locomotor activity and body temperature in C57BL/6 mice. J Neuroendocrinol
2008;20:79–84.
53] Wang G, Anini Y, Wei  W,  Qi X, O’Carroll AM,  Mochizuki T, et al. a new enteric
peptide: localization in the gastrointestinal tract, ontogeny, and stimulation
of gastric cell proliferation and of cholecystokinin secretion. Endocrinology
2004;145:1342–8.
54] Xu N, Wang H, Fan L, Chen Q. Supraspinal administration of apelin-13
induces antinociception via the opioid receptor in mice. Peptides 2009;30:
1153–7.
